Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
Through the collaboration, Lonza will gain access to Singzyme’s enzymatic conjugation platform enabling the site-specific binding of payloads with peptidic linkers to proteins of interest
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
Government Ayurveda College & Hospital will include an infrastructure for the College and a 100 bedded hospital, hostel block for students and staff quarters.
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
